Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
The use of continuous glucose monitoring (CGM) among people with insulin-dependent diabetes has gained wider acceptance, as it has shown benefit in controlling glucose even among those receiving only basal insulin. However, CGM use among non-insulin dependent diabetics, and especially among those with prediabetes or even healthy adults, is not well-established.
In the Sugar Challenge Study, a recent observational study with 665 participants, the use of CGM combined with a mobile app (Sugar AI) providing feedback was evaluated over a 10-day period. A broad range of participants was enrolled, ranging from non-insulin diabetics to normoglycemic individuals over a broad demographic. The primary outcome was the time in range (TIR), defined as a blood glucose of 54-140 mg/dL (54-180 mg/dL for diabetics).
Significant improvement in TIR was found for the entire study population, with the greatest benefit among those with a suboptimal baseline TIR. Surprisingly, those without a previous diagnosis of diabetes had the greatest improvement.
This study, although very short term and without a control group, is an important one, highlighting both the potential benefit of providing immediate and personalized feedback for blood sugar control among both normoglycemic and diabetic individuals, but also the frequency at which glucose dysregulation occurs even among those without diabetes.
Submit this form and you'll receive our latest news and updates.
JAMA Network Open recently published an analysis of several large cohorts of men and women, indicating a lower risk for ...
Learn moreGynecological Endocrinology recently published a systemic review and meta-analysis examining the relationship that glyce...
Learn moreResults of a large population-based observational cohort study examining the association between weight loss and diabete...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment